JAGSONPAL PHARMACEUTICALS
Back to Balance Sheet
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹28 Cr | ₹35 Cr | ₹34 Cr | ₹40 Cr | ₹35 Cr |
What is the latest Total Current Liabilities ratio of JAGSONPAL PHARMACEUTICALS ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹28 Cr |
Mar2023 | ₹35 Cr |
Mar2022 | ₹34 Cr |
Mar2021 | ₹40 Cr |
Mar2020 | ₹35 Cr |
How is Total Current Liabilities of JAGSONPAL PHARMACEUTICALS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹28 Cr | -21.44 | |
Mar2023 | ₹35 Cr | 3.05 | |
Mar2022 | ₹34 Cr | -15.48 | |
Mar2021 | ₹40 Cr | 16.86 | |
Mar2020 | ₹35 Cr | - |
Compare Total Current Liabilities of peers of JAGSONPAL PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JAGSONPAL PHARMACEUTICALS | ₹1,657.5 Cr | 1.2% | 16.2% | 74.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JAGSONPAL PHARMACEUTICALS | 1.2% |
16.2% |
74.7% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses